Back to search
Invasive Thymoma and Thymic Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Thymoma and Thymic Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Thymoma and Thymic Carcinoma trials you may qualify forRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to compare the…
This is an investigational, single arm study.
Exploratory study to examine the effect(s) of Imatinib mesylate treatment on life threatening rare diseases with known associations to one or more Imatinib mesy…
This phase II trial is studying how well saracatinib works in treating patients with relapsed or refractory thymoma or thymic cancer. Saracatinib may stop the g…
This is a phase III, randomized, double-blind, placebo-controlled, multicenter study of the clinical response to fentanyl sublingual spray as a treatment for br…
To assess the efficacy and safety of the regimen in previously untreated, unresectable invasive thymoma or thymic carcinoma